Navigation Links
Dr. Michael Hanley Joins Celtaxsys as CEO
Date:12/2/2010

ATLANTA, Dec. 2, 2010 /PRNewswire/ -- Georgia -based drug discovery start-up, Celtaxsys, Inc. is pleased to announce that Dr. Michael Hanley has joined the company as its new Chief Executive Officer and Chairman of the Board of Directors.  Dr. Hanley has served on both the Scientific Advisory Board and Board of Directors of Celtaxsys since 2007. Dr. Hanley brings more than 20 years of managerial experience in the international life science industry including drug discovery, product development, and production.  He was most recently the Chief Scientific Officer for Amylin Pharmaceuticals where he was responsible for discovery research and preclinical development.  

"We are very pleased that Dr. Hanley has joined us as CEO," says William Reddick, CFO and Founder of Celtaxsys. "His background as an industry leader, and as an innovative drug hunter, with direct knowledge of our area of research, are qualities well-matched to our needs. We are delighted in the strengths he brings to Celtaxsys."  

"Over the last few years I have gained an insight into the innovative technology and exciting research and development that are at the core of Celtaxsys. I look forward towards building long-term, future success and stakeholder value at the Company," says Michael Hanley.  

From 1981 to 1997, Dr. Hanley held faculty positions at Imperial College, London, the Medical Research Council Laboratories, Cambridge, and the University of California at Davis, where he was Professor of Biological Chemistry. From 1997 to 2003, he was a senior consultant for healthcare investors in the venture capital and banking communities and for biotechnology companies such as Cell Therapeutics, Zymogenetics, Elan Pharmaceuticals, and Chiron. Dr. Hanley has founded several start-ups, such as Resolvyx Pharmaceuticals and Psylin Neurosciences, and is currently on boards of Aileron Therapeutics, Metabolic Solutions Development Company, Isogenica, and Pieris.
'/>"/>

SOURCE Celtaxsys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of a New Dermal Patch for Parkinsons Disease
2. Vaccinogen Names Veteran Biotech Executive Michael Kranda President & CEO
3. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
4. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
5. Canadas Michael Smith Genome Sciences Center Validates NEBNext™ DNA Sample Preparation Reagents From New England Biolabs for Use in Next Generation Sequencing
6. Michael Garippa Joins SynCardia as President
7. 2010 Michael E. DeBakey Journalism Awards Announced
8. Michael Youssef Offers Insight into the Muslim Perspective on Oil and the World Economy
9. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
10. Michael Sitaras of SavATree Earns ISA Certified Arborist Designation
11. Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... from TU Delft and VU University Amsterdam in the Netherlands ... influences the speed with which hydrogen gas is released when ... the nanoparticle, the greater the speed at which the hydrogen ... publish their findings in the October issue of the scientific ...
... Children,s Oncology Group (COG) and APEIRON ... investigate Apeiron,s APN301 in a clinical phase II study ... (Apeiron) and the Children,s Oncology Group (COG) today announced ... in neuroblastoma patients. Neuroblastoma, a cancer of the nervous ...
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), today ... accepted for poster presentations and an oral presentation at ... Society. This meeting will be held October 1-5, 2011 ... Details on the presentation times are ...
Cached Biology Technology:Hydrogen released to fuel cell more quickly when stored in metal nanoparticles 2Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 2Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 3Children's Oncology Group and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma With hu14.18-IL2 (APN301) 4Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society 2
(Date:4/15/2014)... high sea levels will rise into the next century, ... University scientist Rene Price. , Price is also affiliated ... Long-Term Ecological Research (LTER) site, one of 25 such ... deserts, mountains to salt marshes around the world. , ... the most certain consequences of climate change. , But ...
(Date:4/15/2014)... University of Missouri researchers have previously shown that ... to exercise exists. In a new study, Frank Booth, ... has found a potential link between the genetic pre-disposition ... at which mental maturation occurs. , For his study, ... extreme activity or extreme laziness. Booth then put the ...
(Date:4/15/2014)... the deadliest infectious diseases recognized the contributions of Frederick ... University of Texas Medical Branch, with a Lifetime Achievement ... The filoviruses include Ebola and Marburg viruses that cause ... The current outbreak of Ebola virus raging in West ... , "This award represents the culmination of a ...
Breaking Biology News(10 mins):Long-term predictions for Miami sea level rise could be available relatively soon 2Genetic pre-disposition toward exercise and mental development may be linked 2International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3
... $7.5 million grant to a multi-university consortium led by the ... insects and bats in order to develop aerial vehicles that ... such as zooming through dense forests or landing on moving ... or in very controlled environments," said principal investigator Kristi Morgansen, ...
... This release is available in Spanish . ... Athens, Georgia, have reported for the first time that ... aspergilli, are capable of infecting corn and peanuts as ... these species produced mycotoxins. Using a molecular procedure ...
... (BRONX, NY) The National Institute of General ... of Medicine of Yeshiva University a five-year, $30 ... thousands of biomedically important proteins. "Determining the structures ... role in normal biological processes as well as in ...
Cached Biology News:UW leading $7.5 million study of animal flight and aerial vehicles 2Black aspergilli species responsible for infecting corn identified 2Einstein receives $30 million to study protein form and function 2Einstein receives $30 million to study protein form and function 3Einstein receives $30 million to study protein form and function 4
... Gene expression profiling allows a high-throuput screening ... naturally occuring or artifitially induced changes in ... that system can be detected, studied, classified ... broad range of genes at a glance. ...
... SYBR Green II RNA gel stain ... stain that has bright fluorescence when bound ... making it ideal for use with either ... or standard UV transilluminators. A 500 µL ...
Rabbit polyclonal to Esa1 ( Abpromise for all tested applications)....
... RNA gel stain is a sensitive nucleic ... bound to RNA and low background in gels, ... or polyacrylamide gels using laser scanners or standard ... 500 µL unit size (S-7564) and a special ...
Biology Products: